Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Isoform-specific mechanisms of α3β4*-nicotinic acetylcholine receptor modulation by the prototoxin lynx1.

George AA, Bloy A, Miwa JM, Lindstrom JM, Lukas RJ, Whiteaker P.

FASEB J. 2017 Jan 18. pii: fj.201600733R. doi: 10.1096/fj.201600733R. [Epub ahead of print]

PMID:
28100642
2.

Genetic Risk for Lung Cancer and the Benefits of Quitting Smoking.

Hall FS.

EBioMedicine. 2016 Sep;11:19-20. doi: 10.1016/j.ebiom.2016.08.026. Epub 2016 Aug 18. No abstract available.

3.

Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis.

Chen LS, Baker T, Hung RJ, Horton A, Culverhouse R, Hartz S, Saccone N, Cheng I, Deng B, Han Y, Hansen HM, Horsman J, Kim C, Rosenberger A, Aben KK, Andrew AS, Chang SC, Saum KU, Dienemann H, Hatsukami DK, Johnson EO, Pande M, Wrensch MR, McLaughlin J, Skaug V, van der Heijden EH, Wampfler J, Wenzlaff A, Woll P, Zienolddiny S, Bickeböller H, Brenner H, Duell EJ, Haugen A, Brüske I, Kiemeney LA, Lazarus P, Le Marchand L, Liu G, Mayordomo J, Risch A, Schwartz AG, Teare MD, Wu X, Wiencke JK, Yang P, Zhang ZF, Spitz MR, Amos CI, Bierut LJ.

EBioMedicine. 2016 Sep;11:219-226. doi: 10.1016/j.ebiom.2016.08.012. Epub 2016 Aug 10.

4.

Pathways to precision medicine in smoking cessation treatments.

Chen LS, Horton A, Bierut L.

Neurosci Lett. 2016 May 18. pii: S0304-3940(16)30345-7. doi: 10.1016/j.neulet.2016.05.033. [Epub ahead of print] Review.

PMID:
27208830
5.

Genome-wide single nucleotide polymorphism heritability of nicotine dependence as a multidimensional phenotype.

Bidwell LC, Palmer RH, Brick L, McGeary JE, Knopik VS.

Psychol Med. 2016 Jul;46(10):2059-69. doi: 10.1017/S0033291716000453. Epub 2016 Apr 7.

PMID:
27052577
6.

CHRNA5/A3/B4 Variant rs3743078 and Nicotine-Related Phenotypes: Indirect Effects Through Nicotine Craving.

Shmulewitz D, Meyers JL, Wall MM, Aharonovich E, Frisch A, Spivak B, Weizman A, Edenberg HJ, Gelernter J, Hasin DS.

J Stud Alcohol Drugs. 2016 Mar;77(2):227-37.

7.

Smokescreen: a targeted genotyping array for addiction research.

Baurley JW, Edlund CK, Pardamean CI, Conti DV, Bergen AW.

BMC Genomics. 2016 Feb 27;17:145. doi: 10.1186/s12864-016-2495-7.

8.

An initial investigation of associations between dopamine-linked genetic variation and smoking motives in African Americans.

Bidwell LC, McGeary JE, Gray JC, Palmer RH, Knopik VS, MacKillop J.

Pharmacol Biochem Behav. 2015 Nov;138:104-10. doi: 10.1016/j.pbb.2015.09.018. Epub 2015 Sep 26.

9.

Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use.

Melroy-Greif WE, Stitzel JA, Ehringer MA.

Genes Brain Behav. 2016 Jan;15(1):89-107. doi: 10.1111/gbb.12251. Epub 2015 Dec 23. Review.

10.

Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation.

Chen LS, Baker TB, Jorenby D, Piper M, Saccone N, Johnson E, Breslau N, Hatsukami D, Carney RM, Bierut LJ.

Drug Alcohol Depend. 2015 Sep 1;154:278-82. doi: 10.1016/j.drugalcdep.2015.06.022. Epub 2015 Jun 23.

11.

Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction.

Reyes-Gibby CC, Yuan C, Wang J, Yeung SC, Shete S.

BMC Syst Biol. 2015 Jun 5;9:25. doi: 10.1186/s12918-015-0167-x.

12.

Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking.

Tyndale RF, Zhu AZ, George TP, Cinciripini P, Hawk LW Jr, Schnoll RA, Swan GE, Benowitz NL, Heitjan DF, Lerman C; PGRN-PNAT Research Group..

PLoS One. 2015 May 26;10(5):e0128109. doi: 10.1371/journal.pone.0128109. eCollection 2015 May 26.

13.

A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.

Jensen KP, DeVito EE, Herman AI, Valentine GW, Gelernter J, Sofuoglu M.

Neuropsychopharmacology. 2015 Nov;40(12):2813-21. doi: 10.1038/npp.2015.131. Epub 2015 May 7.

14.

Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date.

Mamoun M, Bergen AW, Shieh J, Wiggins A, Brody AL.

CNS Drugs. 2015 May;29(5):359-69. doi: 10.1007/s40263-015-0243-1. Review.

15.

CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.

Chen LS, Hung RJ, Baker T, Horton A, Culverhouse R, Saccone N, Cheng I, Deng B, Han Y, Hansen HM, Horsman J, Kim C, Lutz S, Rosenberger A, Aben KK, Andrew AS, Breslau N, Chang SC, Dieffenbach AK, Dienemann H, Frederiksen B, Han J, Hatsukami DK, Johnson EO, Pande M, Wrensch MR, McLaughlin J, Skaug V, van der Heijden HF, Wampfler J, Wenzlaff A, Woll P, Zienolddiny S, Bickeböller H, Brenner H, Duell EJ, Haugen A, Heinrich J, Hokanson JE, Hunter DJ, Kiemeney LA, Lazarus P, Le Marchand L, Liu G, Mayordomo J, Risch A, Schwartz AG, Teare D, Wu X, Wiencke JK, Yang P, Zhang ZF, Spitz MR, Kraft P, Amos CI, Bierut LJ.

J Natl Cancer Inst. 2015 Apr 14;107(5). pii: djv100. doi: 10.1093/jnci/djv100. Print 2015 May. Review.

16.

Nicotine withdrawal.

McLaughlin I, Dani JA, De Biasi M.

Curr Top Behav Neurosci. 2015;24:99-123. doi: 10.1007/978-3-319-13482-6_4. Review.

17.

Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.

Sarginson JE, Killen JD, Lazzeroni LC, Fortmann SP, Ryan HS, Ameli N, Schatzberg AF, Murphy GM Jr.

Nicotine Tob Res. 2015 Sep;17(9):1126-33. doi: 10.1093/ntr/ntu273. Epub 2015 Jan 8.

18.

Genetic variants and early cigarette smoking and nicotine dependence phenotypes in adolescents.

O'Loughlin J, Sylvestre MP, Labbe A, Low NC, Roy-Gagnon MH, Dugas EN, Karp I, Engert JC.

PLoS One. 2014 Dec 29;9(12):e115716. doi: 10.1371/journal.pone.0115716. eCollection 2014 Dec 29.

19.

Examination of the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68) Factor Structure in a Sample of Pregnant Smokers.

Parrott CE, Rathnayaka N, Blalock JA, Minnix JA, Cinciripini PM, Vincent JP, Wetter DW, Green C.

Nicotine Tob Res. 2015 Jun;17(6):653-60. doi: 10.1093/ntr/ntu238. Epub 2014 Dec 4.

20.

New mechanisms and perspectives in nicotine withdrawal.

Jackson KJ, Muldoon PP, De Biasi M, Damaj MI.

Neuropharmacology. 2015 Sep;96(Pt B):223-34. doi: 10.1016/j.neuropharm.2014.11.009. Epub 2014 Nov 26. Review.

Supplemental Content

Support Center